SRX Global Inc. filed an amendment to correct a typographical error in its prior report by clarifying that Carolina Martinez serves as the Chief Financial Officer, not the CEO. The filing also discloses a private placement closing on July 27, 2026, where the company issued 4,340 shares of Series B convertible preferred stock and 284,156 warrants for approximately $3.472 million in cash proceeds. This transaction reflects the final tranche under a Securities Purchase Agreement initiated on March 16, 2026, bringing total aggregate proceeds to approximately $8.0 million. The warrant count was adjusted to account for the company's previously announced 60-for-1 reverse stock split effective July 2, 2026. SRX Global Inc. operates in the healthcare sector.
